Stephen G Waxman Selected Research

NSC 23766

1/2017	Dendritic spine dysgenesis in superficial dorsal horn sensory neurons after spinal cord injury.
10/2013	Burn injury-induced mechanical allodynia is maintained by Rac1-regulated dendritic spine dysgenesis.
12/2011	Rac1-regulated dendritic spine remodeling contributes to neuropathic pain after peripheral nerve injury.
12/2008	Neuropathic pain memory is maintained by Rac1-regulated dendritic spine remodeling after spinal cord injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen G Waxman Research Topics

Disease

107	Pain (Aches) 06/2022 - 10/2003
42	Neuralgia (Stump Neuralgia) 06/2022 - 09/2002
36	Erythromelalgia (Erythermalgia) 01/2021 - 09/2004
19	Multiple Sclerosis 01/2015 - 03/2002
16	Chronic Pain 01/2018 - 06/2005
14	Spinal Cord Injuries (Spinal Cord Injury) 04/2021 - 11/2002
13	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2015 - 10/2002
12	Small Fiber Neuropathy 01/2021 - 11/2012
11	Hyperalgesia 01/2020 - 12/2002
10	Peripheral Nervous System Diseases (PNS Diseases) 06/2022 - 06/2014
9	Channelopathies 01/2019 - 06/2005
9	Paroxysmal Extreme Pain Disorder 01/2017 - 12/2007
8	Demyelinating Diseases (Demyelinating Disease) 11/2008 - 10/2002
8	Neuroinflammatory Diseases 11/2008 - 09/2003
7	Painful Neuropathy 01/2020 - 09/2004
7	Inflammation (Inflammations) 02/2014 - 04/2004
6	Epilepsy (Aura) 09/2014 - 11/2002
5	Diabetic Neuropathies (Diabetic Neuropathy) 06/2022 - 09/2002
5	Congenital Pain Insensitivity 01/2020 - 12/2007
5	Neuroma 10/2013 - 12/2008
5	Peripheral Nerve Injuries 10/2013 - 10/2003
4	Trigeminal Neuralgia (Tic Douloureux) 02/2021 - 04/2017
4	Cerebellar Diseases (Cerebellar Syndrome) 01/2015 - 01/2005
4	Wounds and Injuries (Trauma) 07/2014 - 11/2008
4	Burns 10/2013 - 11/2010
3	Diabetes Mellitus 01/2019 - 08/2002
3	Contusions 12/2008 - 10/2003
2	Somatoform Disorders (Somatoform Disorder) 01/2017 - 01/2017
2	Ataxia (Dyssynergia) 01/2015 - 03/2002
2	Brain Diseases (Brain Disorder) 11/2014 - 09/2014
2	Stroke (Strokes) 05/2012 - 06/2011
2	Hypoxia (Hypoxemia) 11/2008 - 07/2005
2	Seizures (Absence Seizure) 03/2008 - 04/2007
2	Paralysis (Palsy) 04/2007 - 11/2003
1	Facial Pain (Myofacial Pain) 10/2020
1	Hyperopia (Hypermetropia) 07/2020
1	Myopia 07/2020
1	Astigmatism 07/2020

Drug/Important Bio-Agent (IBA)

118	Sodium Channels (Sodium Channel)IBA 12/2021 - 03/2002
52	Voltage-Gated Sodium ChannelsIBA 01/2021 - 11/2002
17	SodiumIBA 01/2022 - 03/2002
16	Ion Channels (Ion Channel)IBA 06/2022 - 09/2002
14	Protein Isoforms (Isoforms)IBA 12/2021 - 11/2004
13	Pharmaceutical PreparationsIBA 01/2022 - 01/2009
13	Proteins (Proteins, Gene)FDA Link 04/2021 - 12/2002
12	Sodium Channel BlockersIBA 12/2020 - 08/2004
9	Messenger RNA (mRNA)IBA 08/2014 - 12/2002
8	Carbamazepine (Tegretol)FDA LinkGeneric 11/2018 - 07/2007
7	Phenytoin (Dilantin)FDA LinkGeneric 11/2008 - 10/2002
6	Tetrodotoxin (Tetradotoxin)IBA 11/2020 - 04/2004
5	Analgesics (Analgesic Drugs)IBA 11/2020 - 10/2014
4	NSC 23766IBA 01/2017 - 12/2008
4	Adenosine Triphosphate (ATP)IBA 01/2016 - 09/2008
4	CalciumIBA 01/2016 - 03/2002
4	Minocycline (Cyclops)FDA LinkGeneric 11/2010 - 04/2006
3	Lacosamide FDA Link 01/2021 - 01/2019
3	AntibodiesIBA 01/2015 - 07/2003
3	Streptozocin (Streptozotocin)FDA Link 05/2012 - 09/2002
2	Protein Kinases (Protein Kinase)IBA 10/2021 - 08/2004
2	DexpramipexoleIBA 01/2020 - 01/2020
2	Opioid Analgesics (Opioids)IBA 01/2020 - 08/2015
2	CarrageenanIBA 01/2017 - 04/2004
2	Adenosine Triphosphatases (ATPase)IBA 01/2016 - 10/2013
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 08/2014
2	Amino Acids FDA Link 10/2014 - 11/2006
2	DNA (Deoxyribonucleic Acid)IBA 09/2014 - 01/2004
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2013 - 02/2010
2	Neuroprotective AgentsIBA 05/2012 - 01/2005
2	salicylhydroxamic acid (SHAM)IBA 12/2011 - 12/2008
2	MitogensIBA 08/2011 - 12/2008
2	Phosphotransferases (Kinase)IBA 08/2011 - 12/2008
2	Lidocaine (Xylocaine)FDA LinkGeneric 11/2010 - 06/2007
2	p38 Mitogen-Activated Protein KinasesIBA 11/2010 - 03/2008
2	Mitogen-Activated Protein KinasesIBA 12/2008 - 07/2005
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2008 - 02/2007
2	OligodeoxyribonucleotidesIBA 05/2004 - 10/2003
2	Vasopressins (Vasopressin)IBA 03/2004 - 08/2002
1	Scorpion Venoms (Scorpion Venom)IBA 01/2022
1	CytokinesIBA 10/2021
1	CationsIBA 02/2021
1	Menthol FDA Link 02/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 10/2020
1	Biological FactorsIBA 10/2020
1	Naloxone (Narcan)FDA LinkGeneric 01/2020
1	benzothiazoleIBA 01/2020
1	CannabinoidsIBA 01/2020
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2020
1	Transient Receptor Potential ChannelsIBA 01/2020
1	Vincristine (Oncovin)FDA LinkGeneric 01/2020

Therapy/Procedure

19	Therapeutics 01/2022 - 01/2004
13	Drug Therapy (Chemotherapy) 01/2021 - 06/2008
3	Transplantation 05/2012 - 03/2006
2	Analgesia 12/2020 - 01/2020
2	Intradermal Injections 10/2013 - 08/2004
2	Axotomy 11/2002 - 09/2002
1	Intravenous Infusions 04/2021
1	Photorefractive Keratectomy 07/2020
1	Lasers (Laser) 07/2020
1	Refractive Surgical Procedures 07/2020